Potential usage of thermosensitive liposomes for site-specific delivery of cytokines

Cancer Letters

Volumn 155, Issue 1, 2000, Pages 71-77

  Yuyama, Yukino ^a   Tsujimoto, Masafumi ^b   Fujimoto, Yoshiko ^a   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Drug delivery; Liposome; Thermosensitive liposome; Tumor necrosis factor

Indexed keywords

CYTOKINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLCHOLINE; GLUCURONIC ACID; GLUCURONIDE; HUMAN SERUM ALBUMIN; LIPOSOME; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HEAT SENSITIVITY; HEATING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CELL SURVIVAL; CYTOKINES; GLUCURONATES; HEAT; HUMANS; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SARCOMA, EXPERIMENTAL; SERUM ALBUMIN; TEMPERATURE; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0034601233     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00410-9     Document Type: Article

References (28)

1. Namba Y., Sakakibara T., Masada M., Ito F., Oku N. Glucuronate-modified liposomes with prolonged circulation time. Chem. Pharm. Bull. 38:1990;1663-1666.
2. Oku N., Namba Y., Okada S. Tumor accumulation of novel RES-avoiding liposomes. Biochim. Biophys. Acta. 1126:1992;255-260.
3. Oku N. Anticancer therapy using glucuronate modified long-circulating liposomes. Adv. Drug Deliv. Rev. 40:1999;63-73.
4. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphiphathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:1990;235-237.
5. Storm G., Woodle M.C. Long circulating liposome therapeutics: From concept to clinical reality. Woodle M.C., Storm G. Long Circulating Liposomes. 1998;3-16 Springer, Berlin.
6. Yatvin M.B., Weinstein J.N., Dennis W.H., Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science. 202:1978;1290-1293.
7. Iga K., Hamaguchi N., Igari Y., Ogawa Y., Gotoh K., Ootsu K., Toguchi H., Shimamoto T. Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia. J. Pharm. Exp. Ther. 257:1991;1203-1207.
8. Merlin J.L., Marchal S., Ramacci C., Notter D., Vigneron C. Antiproliferative activity of thermosensitive liposome-encapsulated doxorubicin combined with 43°C hyperthermia in sensitive and multidrug-resistant MCF-7 cells. Eur. J. Cancer, 29A. 1993;2264-2268.
9. Kono K., Nakai R., Morimoto K., Takagishi T. Thermosensitive polymer-modified liposomes that release contents around physiological temperature. Biochim. Biophys. Acta. 1416:1999;239-250.
10. Oku N., Naruse R., Doi K., Okada S. Potential usage of thermosensitive liposomes for macromolecule delivery. Biochim. Biophys. Acta. 1191:1994;389-391.
11. Hori T., Kashiyama S., Oku N., Hayakawa M., Shibamoto S., Tsujimoto M., Nishihara T., Ito F. Effects of tumor necrosis factor on cell growth and expression of transferrin receptors in human fibroblasts. Cell Struct. Funct. 13:1988;425-433.
12. Oku N., Tokudome Y., Tsukada H., Okada S. Real-time analysis of liposomal trafficking in tumor-bearing mice by use of positron emission tomography. Biochim. Biophys. Acta. 1238:1995;86-90.
13. Namba Y., Oku N. Liposomal applications to Cancer Therapy. J. Bioact. Compat. Polymers. 8:1993;158-177.
14. Oku N., Doi K., Namba Y., Okada S. Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sarcoma-bearing mice. Int. J. Cancer. 58:1994;415-419.
15. Tokudome Y., Oku N., Namba Y., Okada S. Antitumor activity of vincristine encapsulated in glucuronide- modified long-circulating liposomes in mice bearing Meth A sarcoma. Biochim. Biophys. Acta. 1279:1996;70-74.
16. Oku N., Tokudome Y., Namba Y., Saito N., Endo M., Hasegawa Y., Kawai M., Tsukada H., Okada S. Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. Biochim. Biophys. Acta. 1280:1996;149-154.
17. Namba Y., Oku N., Ito F., Sakakibara T., Okada S. Liposomal modification with uronate, which endows liposomes with long circulation in vivo. Reduces the uptake of liposomes by J774 cells in vitro, Life Sci. 50:1992;1773-1779.
18. Maruyama K., Unezaki S., Takahashi N., Iwatsuru M. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim. Biophys. Acta. 1149:1993;209-216.
19. Ning S., Macleod K., Abra R.M., Huang A.H., Hahn G.M. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Int. J. Rad. Oncol. Biol. Phys. 29:1994;827-834.
20. Gaber M.H., Wu N.Z., Hong K., Huang S.K., Dewhirst M.W., Papahadjopoulos D. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int. J. Rad. Oncol. Biol. Phys. 36:1996;1177-1187.
21. Iga K., Ohkouchi K., Ogawa Y., Toguchi H. Membrane modification by negatively charged stearyl-polyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticuloendothelial system uptake. J. Drug Targeting. 2:1994;259-267.
22. Ono A., Horikoshi I., Ueno M. Study on hepatic artery chemoembolization using temperature-sensitive liposome or lipiodol emulsion. Biol. Pharm. Bull. 18:1995;279-283.
23. Viroonchatapan E., Sato H., Ueno M., Adachi I., Tazawa K., Horikoshi I. Magnetic targeting of thermosensitive magnetoliposomes to mouse livers in an in situ on-line perfusion system. Life Sci. 58:1996;2251-2261.
24. Malik S.T.A., Balkwill F.R. Antiproliferative and antitmor activity of TNF in vitro and in vivo. Aggarwal B.B., Vilcek J. Tumor Necrosis Factors. 1992;239-268 Marcel Dekker, New York.
25. Kedar E., Palgi O., Golod G., Babai I., Barenholz Y. Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-α show improved pharmacokinetics and biological activity and reduced toxicity in mice, J. Immunother. 20:1997;180-193.
26. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., Hariri R.J., Fahey T.J., Zentella A., Albert J.D., Shires T., Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;470-474.
27. Wakabayashi T., Yoshida J., Ishiyama J., Mizuno M. Antitumor activity of recombinant human tumor necrosis factor-alpha (rH-TNFα) and liposome-entrapped rH-TNFα Neurol. Med.-Chirurg. 37:1997;739-745.
28. Savva M., Duda E., Huang L. genetically modified recombinant tumor necrosis factor-alpha conjugated to the distal terminals of liposomal surface grafted polyethyleneglycol chains. Int. J. Pharm. 184:1999;45-51.